Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection
- 79 Downloads
The presence of hepatitis B virus (HBV) DNA in the absence of traceable hepatitis B surface antigen (HBsAg) in the plasma specimen of patients is defined as occult HBV infection (OBI). This study aimed to detect HBV-DNA in the plasma and peripheral blood mononuclear cells (PBMCs) of Iranian HBsAg negative patients with human immunodeficiency virus (HIV) infection. This cross-sectional study was conducted on 172 patients with HIV infection from September 2015 to August 2017. The patients were tested for serological parameters (HBsAg, HBcAb, HBeAg and HBeAb) against HBV infection. Moreover, they were tested for HBV viral load (using COBAS TaqMan 48 Kit, Roche, USA) in plasma and the presence of the HBV genome in PBMC specimens using real-time PCR. The mean age of the patients was 35.4 ± 13.4 years. Of the 172 studied patients, 109 (63.4%) were male. In this study, 151 (87.8%) patients were negative for HBsAg, 111 (64.5%) patients were negative for all HBV infection serological markers, 9 (5.2%) patients were only positive for HBsAg and 29 (16.9%) patients were only positive for HBcAb. Moreover, five (3.3%) patients with HBsAg negative had OBI (in the plasma sample of four patients and PBMC specimens of all five patients, HBV-DNA was detected). The present study revealed that 3.3% of the patients with HIV infection had occult HBV infection. Presumably, designing prospective studies to identify this infection in patients with HIV infection is informative and valuable.
The authors of the present research would like to thank all the candidates who enrolled in this study.
Sources of funding
The current study was financially supported by Research Deputy of Iran University of Medical Sciences (grant number: 27008).
Compliance with ethical standards
Conflicts of interest
The authors of the current research declare no conflict(s) of interest.
Ethical approval for the current study was received from the local ethics committee of the Iran University of Medical Sciences (IUMS), Tehran, Iran. All of the participants were informed about the present research, with a written consent form obtained from them prior to their enrollment. All the experiments were done in the HIV Laboratory of National Centre, Vice Chancellor for Health, IUMS, Tehran, Iran.
- 2.Amitis R, Mohammad B, Ali E, Masoomeh S, Arezoo A (2012) Occult hepatitis B infection in different high risk patients. Hepat Mon 2012:467–468Google Scholar
- 9.hio CL, editor Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment. In: Seminars in liver disease; 2003: Copyright© 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.:+ 1 (212) 584-4662.Google Scholar
- 11.Peters MG (2007) Diagnosis and management of hepatitis B virus and HIV coinfection. Topics HIV Med Publ Int AIDS Soc USA 15(5):163Google Scholar
- 18.Allain J-P (2017) Global epidemiology of occult HBV infection. Ann Blood. 2(7):1–13Google Scholar
- 31.de Almeida Pereira RAR, Mussi ADH, e Silva VCDA, Souto FJD (2006) Hepatitis B Virus infection in HIV-positive population in Brazil: results of a survey in the state of Mato Grosso and a comparative analysis with other regions of Brazil. BMC Infect Dis 6(1):34CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Sadeghi A, Shirvani-Dastgerdi E, Tacke F, Yagmur E, Poortahmasebi V, Poorebrahim M et al (2017) HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg. J Med Virol 89(2):246–256CrossRefPubMedGoogle Scholar
- 35.Jahanbakhsh A, Farzinepoor Z, Mansouri F, Vaziri S, Afsharian M (2017) Prevalence of Occult Hepatitis B in HIV Positive Patients (Adolescents and Adults) in Kermanshah-Iran. Int J Pediatrics. 5(9):5797–5803Google Scholar
- 37.Honarmand A, Pourahmad M, Solhjoo K, Kohan M, Davami MH, Mostafavi Zadeh SK (2014) Occult hepatitis B demonstrated by anti-HBc and HBV DNA in HIV-positive patients. Reports Biochem Mol Biol 3(1):38–42Google Scholar
- 42.Cassini R, De Mitri M, Gibellini D, Urbinati L, Bagaglio S, Morsica G et al (2013) A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection. J Viral Hepat 20(1):42–49CrossRefPubMedGoogle Scholar
- 46.Fabbri G, Mastrorosa I, Vergori A, Mazzotta V, Pinnetti C, Grisetti S et al (2017) Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature. BMC Infect Dis. 17(1):182CrossRefPubMedPubMedCentralGoogle Scholar